Literature DB >> 28716830

Reality and Truth: Balancing the Hope and the Hype of Real-World Evidence.

Anushka Patel1, Laurent Billot2.   

Abstract

Entities:  

Keywords:  Editorials; SGLT proteins; causality; clinical trial; diabetes mellitus; observational study

Mesh：

Substances：

Year:  2017        PMID： 28716830     DOI： 10.1161/CIRCULATIONAHA.117.029233

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study.

Authors:  Gian Paolo Fadini; Giancarlo Zatti; Ileana Baldi; Daniele Bottigliengo; Agostino Consoli; Andrea Giaccari; Giorgio Sesti; Angelo Avogaro
Journal:  Diabetes Obes Metab       Date:  2018-03-30       Impact factor: 6.577

2.  Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study.

Authors:  Gian Paolo Fadini; Anna Solini; Maria Laura Manca; Giuseppe Penno; Adriano Gatti; Roberto Anichini; Stefano Del Prato; Angelo Avogaro
Journal:  Diabetes Obes Metab       Date:  2018-09-21       Impact factor: 6.577

3.  Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System.

Authors:  Gian Paolo Fadini; Mayur Sarangdhar; Angelo Avogaro
Journal:  BMJ Open Diabetes Res Care       Date:  2018-01-30

4.  Patient Recruitment Into a Multicenter Clinical Cohort Linking Electronic Health Records From 5 Health Systems: Cross-sectional Analysis.

Authors:  Wendy L Bennett; Carolyn T Bramante; Scott D Rothenberger; Jennifer L Kraschnewski; Sharon J Herring; Michelle R Lent; Jeanne M Clark; Molly B Conroy; Harold Lehmann; Nickie Cappella; Megan Gauvey-Kern; Jody McCullough; Kathleen M McTigue
Journal:  J Med Internet Res       Date:  2021-05-27       Impact factor: 5.428
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.